ENGENE HOLDINGS INC (ENGN) Stock Price, Quote, News and Overview
NASDAQ:ENGN - Nasdaq - CA29286M1059 - Common Stock - Currency: USD
ENGN Quote, Performance and Key Statistics
5.25
-0.06 (-1.13%)
The current stock price of ENGN is 5.25 USD. In the past month the price decreased by -17.32%. In the past year, price decreased by -67.21%.
ENGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About ENGN
Company Profile
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. The company is headquartered in Saint-Laurent, Quebec and currently employs 33 full-time employees. The company went IPO on 2021-12-10. The Company, through its subsidiary, enGene Inc., is engaged in developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues. The Company’s proprietary dually derived chitosan (DDX) platform has a high degree of payload flexibility, including DNA and various forms of RNA with broad tissue and disease application. In preclinical animal and in vitro models, the Company’s DDX technology has been demonstrated to effectively induce expression of therapeutic genes following delivery to the lung, gastrointestinal tract, and urinary tract, and its lead product detalimogene voraplasmid (EG-70) is being developed for the treatment of bacillus calmette-guerin (BCG)-resistant non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS). EG-70 is a novel non-viral gene therapy designed to elicit a local immune response following the delivery to the bladder urothelium.
Company Info
ENGENE HOLDINGS INC
4868 Rue Levy, Suite 220
Saint-Laurent QUEBEC CA
Employees: 32
Company Website: https://engene.com/
Investor Relations: http://www.engene.com/investors/
Phone: 15143324888
ENGENE HOLDINGS INC / ENGN FAQ
What is the stock price of ENGENE HOLDINGS INC today?
The current stock price of ENGN is 5.25 USD. The price decreased by -1.13% in the last trading session.
What is the ticker symbol for ENGENE HOLDINGS INC stock?
The exchange symbol of ENGENE HOLDINGS INC is ENGN and it is listed on the Nasdaq exchange.
On which exchange is ENGN stock listed?
ENGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ENGENE HOLDINGS INC stock?
17 analysts have analysed ENGN and the average price target is 25.59 USD. This implies a price increase of 387.48% is expected in the next year compared to the current price of 5.25. Check the ENGENE HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ENGENE HOLDINGS INC worth?
ENGENE HOLDINGS INC (ENGN) has a market capitalization of 267.64M USD. This makes ENGN a Micro Cap stock.
How many employees does ENGENE HOLDINGS INC have?
ENGENE HOLDINGS INC (ENGN) currently has 32 employees.
What are the support and resistance levels for ENGENE HOLDINGS INC (ENGN) stock?
ENGENE HOLDINGS INC (ENGN) has a resistance level at 5.97. Check the full technical report for a detailed analysis of ENGN support and resistance levels.
Should I buy ENGENE HOLDINGS INC (ENGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ENGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ENGN, evaluating the profitability, health, valuation and growth aspects
- ENGENE HOLDINGS INC (ENGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ENGENE HOLDINGS INC (ENGN) Sales and EPS estimates to see what analysts future expectations are.
- ENGENE HOLDINGS INC (ENGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ENGENE HOLDINGS INC (ENGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ENGENE HOLDINGS INC (ENGN) Stock Chart to make your own analysis
- ENGENE HOLDINGS INC (ENGN) Latest news and press-releases to stay up to date.
Does ENGENE HOLDINGS INC (ENGN) stock pay dividends?
ENGN does not pay a dividend.
When does ENGENE HOLDINGS INC (ENGN) report earnings?
ENGENE HOLDINGS INC (ENGN) will report earnings on 2025-03-17.
What is the Price/Earnings (PE) ratio of ENGENE HOLDINGS INC (ENGN)?
ENGENE HOLDINGS INC (ENGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.51).
ENGN Technical Analysis
ENGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENGN. ENGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ENGN Financial Highlights
Over the last trailing twelve months ENGN reported a non-GAAP Earnings per Share(EPS) of -1.51. The EPS decreased by -483.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.72% | ||
| ROE | -20.23% | ||
| Debt/Equity | 0.08 |
ENGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to ENGN. The Buy consensus is the average rating of analysts ratings from 17 analysts.